ERBB2 c.1417C>T ;(p.H473Y)

Variant ID: 17-37872096-C-T

NM_004448.2(ERBB2):c.1417C>T;(p.H473Y)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons.

Frontiers In Immunology
Zhao, Qijie Q; Jiang, Yu Y; Xiang, Shixin S; Kaboli, Parham Jabbarzadeh PJ; Shen, Jing J; Zhao, Yueshui Y; Wu, Xu X; Du, Fukuan F; Li, Mingxing M; Cho, Chi Hin CH; Li, Jing J; Wen, Qinglian Q; Liu, Tao T; Yi, Tao T; Xiao, Zhangang Z
Publication Date: 2021

Variant appearance in text: ERBB2: H473Y
PubMed Link: 33859650
Variant Present in the following documents:
  • Main text
View BVdb publication page



TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes.

Bmc Bioinformatics
Zhang, Guanglan G; Chitkushev, Lou L; Olsen, Lars Rønn LR; Keskin, Derin B DB; Brusic, Vladimir V
Publication Date: 2021-04-14

Variant appearance in text: HER2: H473Y
PubMed Link: 33849445
Variant Present in the following documents:
  • Main text
  • 12859_2021_Article_3962.pdf
View BVdb publication page



Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.

Molecular Therapy : The Journal Of The American Society Of Gene Therapy
Deniger, Drew C DC; Pasetto, Anna A; Tran, Eric E; Parkhurst, Maria R MR; Cohen, Cyrille J CJ; Robbins, Paul F PF; Cooper, Laurence Jn LJ; Rosenberg, Steven A SA
Publication Date: 2016-06

Variant appearance in text: ERBB2: H473Y
PubMed Link: 26945006
Variant Present in the following documents:
  • Main text
View BVdb publication page



Recurrent inactivating RASA2 mutations in melanoma.

Nature Genetics
Arafeh, Rand R; Qutob, Nouar N; Emmanuel, Rafi R; Keren-Paz, Alona A; Madore, Jason J; Elkahloun, Abdel A; Wilmott, James S JS; Gartner, Jared J JJ; Di Pizio, Antonella A; Winograd-Katz, Sabina S; Sindiri, Sivasish S; Rotkopf, Ron R; Dutton-Regester, Ken K; Johansson, Peter P; Pritchard, Antonia L AL; Waddell, Nicola N; Hill, Victoria K VK; Lin, Jimmy C JC; Hevroni, Yael Y; Rosenberg, Steven A SA; Khan, Javed J; Ben-Dor, Shifra S; Niv, Masha Y MY; Ulitsky, Igor I; Mann, Graham J GJ; Scolyer, Richard A RA; Hayward, Nicholas K NK; Samuels, Yardena Y
Publication Date: 2015-12

Variant appearance in text: ERBB2: H473Y
PubMed Link: 26502337
Variant Present in the following documents:
  • NIHMS65345-supplement-Supplementary_table_3.xlsx, sheet 1
  • NIHMS65345-supplement-Supplementary_table_1.xlsx, sheet 1
  • NIHMS65345-supplement-Supplementary_table_3.xlsx, sheet 2
View BVdb publication page



A highly recurrent RPS27 5'UTR mutation in melanoma.

Oncotarget
Dutton-Regester, Ken K; Gartner, Jared J JJ; Emmanuel, Rafi R; Qutob, Nouar N; Davies, Michael A MA; Gershenwald, Jeffrey E JE; Robinson, William W; Robinson, Steven S; Rosenberg, Steven A SA; Scolyer, Richard A RA; Mann, Graham J GJ; Thompson, John F JF; Hayward, Nicholas K NK; Samuels, Yardena Y
Publication Date: 2014-05-30

Variant appearance in text: ERBB2: 1417C>T; H473Y
PubMed Link: 24913145
Variant Present in the following documents:
  • oncotarget-05-2912-s003.xlsx, sheet 1
View BVdb publication page